Johansson L, Lefèvre J P, Nowak P. "Method for the Synthesis of (E)-3-(4-Methoxyphenyl)-1-(piperidin-1-yl)prop-2-en-1-one" [P]. European Patent, EP 3254403 A1, 2017-08-25.
发明人马晓峰,陈志强,冯建国. "A Process for Preparing High-Purity (E)-3-(4-Methoxyphenyl)-1-(piperidin-1-yl)prop-2-en-1-one" [P]. 中国发明专利, 专利号 CN 116678973 B, 授权公告日 2017-02-05.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2016, 1921, (6), 3407-3413.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2025, 1296, 5547-5573.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of (E)-3-(4-Methoxyphenyl)-1-(piperidin-1-yl)prop-2-en-1-one Using HRMS and NMR". Biomed. Chromatogr., 2019, 2033, (6), 6999-7009.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2018, 1319, 4776-4782.